Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Learn practical methods to use spending analysis for sharper budgeting. This guide shows how to turn data into smarter spending decisions.
19,062 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Marvell Technology recently joined a prestigious club by entering the S&P 500, set to start trading in June. This gui...
Adobe has been down over past year, testing investors' patience. This guide breaks down the root causes, outlines act...
While Nvidia grabs the spotlight with GPUs, Broadcom quietly powers AI at scale with custom accelerators. This articl...
Investors woke up to a surge in Qualcomm stock after the company outlined bold AI-backed growth targets. This article...
Rivian surprised investors with higher-than-expected Q2 deliveries and a raised full-year delivery outlook. This arti...
META faces a rough patch after a sharp pullback, but analysts say a credible case for upside exists as AI monetizatio...
Investors want to know how far the S&P 500 can rise. Wall Street analysts see potential, but also risk. This guide ex...
Agentic AI could automate payments and settlements in crypto, but it needs solid blockchain rails. This piece breaks ...
Roku stock has slipped about 17% year-to-date, even as the company shows improving profitability and optimism for gro...
Ethereum has seen price swings as reports surface that ethereum founder vitalik buterin has been selling portions of ...
Plug Power stock popped after-hours following a strong Q4 showing and raised 2026 guidance. This article breaks down ...